Stock Region Penny Picks
Stock Region Watchlist: Your Morning Market Movers.
Stock Region Watchlist: Your Morning Market Movers
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information in this newsletter is for informational and entertainment purposes only. It is not financial advice. All investing involves risk, and you should do your own research before making any investment decisions. The opinions expressed here are our own and do not represent a recommendation to buy or sell any security.
What a day it’s been already. The pre-market was buzzing, and the regular session is shaping up to be just as exciting. We’ve got a lot of ground to cover, from major earnings beats to groundbreaking partnerships and some seriously impressive financial results.
Let’s dive into the names lighting up our screens this morning.
Today’s Top Watchlist
$KSS - Kohl’s
Kohl’s just stepped up and delivered an earnings report that completely smashed expectations. They posted earnings of $0.10 per share, blowing the consensus estimate of a 20-cent loss out of the water. That’s a massive 150% beat. While sales were down slightly year-over-year, they still came in ahead of what analysts were predicting. The big news, though, is the appointment of Michael J. Bender as the new CEO. A fresh face at the top combined with a strong earnings surprise could signal a real turning point for the retail giant. Keep an eye on this one for potential momentum.
$CLSK - CleanSpark
Wow. Just... wow. CleanSpark dropped its fiscal year 2025 results, and they are nothing short of spectacular. Revenue hit $766.3 million, a 102% increase from the previous year. It’s not every day you see a company double its revenue. They’ve also grown their contracted power by 43%, setting themselves up for a major push into the AI space. Capping it all off is a recent $1.15 billion, 0% interest transaction. That’s a huge war chest for growth without the burden of interest payments. This company is firing on all cylinders.
$ZJK - ZJK Industrial
Here’s a big move for American manufacturing. ZJK is partnering with Chaince Digital to build a U.S.-based R&D and manufacturing hub for precision components. We’re talking parts for AI and semiconductors, two of the hottest sectors on the planet. With a planned investment of up to $200 million, this is a serious commitment to the “Made in America” strategy. This kind of long-term strategic partnership could lay the groundwork for substantial future growth.
$LNAI - Lunai Bioworks
This is the kind of news that gets the biotech world talking. Lunai announced a landmark breakthrough showing complete tumor regression in humanized cancer models. On the back of that incredible result, they’ve already secured their first licensing Letter of Intent (LOI). This is early-stage, but the potential is enormous. A company making this kind of progress in cancer research is always worth watching closely.
$CETY - CETY
Clean energy continues to be a hot topic, and CETY just landed a significant project. They’ve secured a $10 million battery energy storage project in New York. The company notes this is the first of multiple large-scale systems they expect to roll out. Securing a major contract like this provides a solid revenue stream and proves their capability, potentially opening the door for more deals down the line.
$RELI - Reliance Global Group
In an interesting and bold move, Reliance announced it has consolidated its digital asset treasury into Zcash. This is a big vote of confidence in Zcash specifically and shows the company is serious about its digital asset strategy. It’s a move that sets them apart and could attract investors who are bullish on that particular cryptocurrency.
A Few More to Keep on Your Radar:
$RUBI (Rubico Inc.): Locked in some time charter extensions, bringing their contracted revenue backlog to a solid $120.8 million. Predictable revenue is always a good thing.
$BCTX (BriaCell): They’re heading to a major cancer symposium (SABCS® 2025) to highlight positive clinical data. Positive data presentations can often act as a catalyst.
$VNRX (VolitionRx Limited): Just announced the first sale of its Nu.Q® Cancer Assays for clinical use. Moving from research to commercial sales is a critical milestone for any diagnostics company.
$PMCB (PharmaCyte Biotech): They successfully cashed in on their stake in Femasys. This move strengthens their balance sheet and gives them more capital to deploy strategically. Smart money management.
It’s going to be a fascinating day. Keep your charts open, stay disciplined, and look for your opportunities.
Happy trading!
Final Disclaimer: Remember, we are not financial advisors. The stocks mentioned here are on our watchlist for a reason, but that does not mean they are right for your portfolio. Trading involves significant risk, including the possible loss of principal. Always perform your own due diligence and consult with a licensed professional before making any investment decisions.
CleanSpark doubling revenue and landing that 0% intrest deal is impressive. The pivot towards AI infrastructure makes sense given their power expansion. Solid list today.